Skip to main content

Describe the relationship among the various hemoglobin's in first year of life and their implication in diagnosing hereditary hemoglobinopathies.

Hemoglobin is tetramer of 4 globin chain + heme( Fe containing porphyrin ring).

Hb F has 2 alpha chains and 2 beta chains which is replaced by Hb A which has 2 aplha chains and 2 beta chains.

Hemoglobin F   -   α2 γ2

Hemoglobin A   -  α2 β2

Normal replacement goes as below

  • By 6-8wk HbF is predominate hb
  • By 24wk 
    • HbF constitute 90% of Hb
    • HbA constitute 5-10% of Hb
  • By 6-12mo postnatal age
    • HbF is <2% of total Hb
    • HbA reaches adult level
There could be deviations in this replacement due to mutations in gene which cause replacement of amino acids and forms defective hemoglobins.
Diagnosis is done by HPLC (High Performance Liquid Chromatography) or IEF (Thin layer/Isoelectric Focusing). 

F - fetal Hb
S - sickle Hb
SS - Homozygous SCD
AS - Sickle cell trait
Sβ - Sickle thalassemia
C -  Hb C
SC - sickle-hemoglobin C
A stands for adult Hb
HPFH - Hereditary Presence of Fetal Hemoglobin

Hb are written from greater to lower quantity.

Report

Possibilities

FS

  • SCD SS

  • SCD Sβ thal

  • S HPFH

FSC

  • SCD SC

FSA

  • SCD Sβ thal (Hb S>50%, HbA2>3.5%)

FAS

  • SCD AS (rule out blood transfusion)

AFS

Transfusion is received so can be

  • SCD SS

  • SCD Sβ thal

FS Other

  • SCD Sβ thal

  • SCD SD, SO, SC, S


F98%A22%

β thalassemia major

A65-88%F10-30%,A22-5%

β thalassemia intermediate

↑ A2, variable F

β thalassemia trait

A2 absent

𝛿 thalassemia

Bart: 1-2%

α thalassemia 1 gene deletion

Bart: 5-10%

α thalassemia 2 genes deletion

Bart: 20-30%

α thalassemia 3 genes deletion

Bart: 90% c Grower 1,2 & Portland

α thalassemia 4 genes deletion

Comments

Popular posts from this blog

Management of Neurocysticercosis in Children: Association of Child Neurology Consensus Guidelines

Lab tests: Routine screening of family members of children with NCC is not recommended. If at all screening is performed, fecal testing of the family for ova/cyst can be done. The use of serological tests for diagnosis and clinical decision making in children with NCC is not recommended. Radiological tests: The MRI need not be done following CT in the following situations -  The CT conclusively demonstrates the presence of a scolex within the cyst  In the absence of demonstration of scolex – If a solitary cystic/ring-enhancing lesion has all other typical sizes, shape, and location characteristics of NCC Multiple lesions in different stages are present, including some cystic or ring enhancing or calcified MRI should be considered after CT in the following situations – Atypical imaging features (conglomerate lesions, subarachnoid or intraventricular lesions) along with the absence of scolex CT features create suspicion of intraventricular, subarachnoid, or intraspinal NCC Atypical clin